I made the following post on my Facebook page today concerning this study.
NEUROINFLAMMATION AND CHRONIC FATIGUE SYNDROME
New research (study below) has found evidence of neuroinflammation in chronic fatigue syndrome (ME/CFS). In the study, PET scans revealed inflammation in multiple areas of the brain...read mo...re at:
http://www.nlm.nih.gov/medlineplus/news/fullstory_146023.html
Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study.
Nakatomi Y1, et. al. J Nucl Med. 2014 Mar 24. [Epub ahead of print]
"Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disease characterized by chronic, profound, disabling, and unexplained fatigue...Neuroinflammation is present in widespread brain areas in CFS/ME patients and was associated with the severity of neuropsychologic symptoms."
The activation of the kynurenine pathway (KP) would explain the neuroinflammation in patients with CFS/ME. The KP degrades the essential amino acid tryptophan in the human body. In patients with CFS/ME, fibromyalgia, autoimmune disease, Alzheimer's, and Parkinson's disease the KP is being upregulated by inflammatory cytokines due to a lack of the enzymes protease and DNase 1. This results in the depletion of tryptophan and the production of neurotoxins.
In the following study the researchers concluded that chronic fatigue syndrome and fibromyalgia appear to meet the criteria of a tryptophan-kynurenine pathway disorder.
Kynurenine Pathway Pathologies: do Nicotinamide and Other Pathway Co-Factors have a Therapeutic Role in Reduction of Symptom Severity, Including Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).
Blankfield A. Int J Tryptophan Res. 2013 Jul 21;6(Suppl 1):39-45.
"The definition of dual tryptophan pathways has increased the understanding of the mind-body, body-mind dichotomy. The serotonergic pathway highlights the primary (endogenous) psychiatric disorders. The up-regulation of the kynurenine pathway by physical illnesses can cause neuropathic and immunological disorders1 associated with secondary neuropsychiatric symptoms...Chronic fatigue syndrome (CFS) and fibromyalgia (FM) appear to meet the criteria of a tryptophan-kynurenine pathway disorder with potential neuroimmunological sequelae."
The following studies discuss the involvement of the KP in the neuroinflammation found in Parkinson's disease and diabetes.
The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
Anna Zinger, et. al.
"Parkinson’s disease (PD) is a common neurodegenerative disorder characterised by loss of dopaminergic neurons and localized neuroinflammation occurring in the midbrain several years before the actual onset of symptoms...The KP generates several neuroactive compounds and therefore has either a neurotoxic or neuroprotective effect. There are to date several lines of evidence linking some of the KP intermediates and the neuropathogenesis of PD. Moreover, it is likely that pharmacological modulation of the KP will represent a new therapeutic strategy for PD."
Involvement of the kynurenine pathway and neuroinflammation in diabetes.
Pr. Gilles J. Guillemin et. al
"During neuroinflammation, the KP is activated in brain cells... There is accumulating evidence that the excitotoxin quinolinic acid is involved in the neurotoxicity associated with several inflammatory brain diseases such as Alzheimer's disease, Parkinson's disease, motor neuron diseases, multiple sclerosis (MS) and major psychiatric disorders. We also recently found that the KP is dysregulated in diabetes."